Business Context and Reporting Period
Company: GlaxoSmithKline plc (GSK)
Filing Type: Form 6-K (Report of Foreign Issuer)
Reporting Period: Six months ended June 30, 2006
Filing Date: July 27, 2006
This filing serves as a notification that GSK published its 2006 Half Year Report via advertisements in the Financial Times, the Daily Telegraph, and the Wall Street Journal. The report details the company's results for the first half of 2006.
Key Financial Metrics
The provided text does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. This filing acts solely as a reference to the full Half Year Report available on the company's website and at the UK Listing Authority.
Material Changes
The filing text does not provide specific details on material changes versus the prior comparable period. Investors must refer to the full Half Year Report for comparative analysis.
Guidance, Outlook, and Risks
No specific guidance, outlook, management commentary, risks, contingencies, or unusual items are detailed in this Form 6-K text. The document focuses on the dissemination of the Half Year Report rather than the content of the financial results themselves.
Investor Verification Checklist
- Verify the full 2006 Half Year Report on the GSK website (www.gsk.com) for detailed financial figures.
- Confirm the availability of the report at the UK Listing Authority's Document Viewing Facility in Canary Wharf, London.
- Review the advertisements in the Financial Times, Daily Telegraph, and Wall Street Journal dated July 27, 2006, for summarized highlights.